- U.S. Stock Alert: Nebius Group surged on October 19 following reiterated buy rating, European AI initiative, and AI cloud developments
- Disc Medicine's rare disease drug succeeds in late-stage clinical trials
- Dexco Ends Manufacturing at Cabo de Santo Agostinho Sanitary Ware Plant
- AST SpaceMobile Receives Letter of Intent Satellite Mobile Project From Four European Carriers
- PyroGenesis Canada Receives CA$2.3 Million Payment from Radian for Drosrite Deployment
- SL Green Secures $2 Billion Refinancing for 245 Park Avenue
- EyePoint Pharmaceuticals to Cut 53% of Workforce After Eye Disease Drug Trial Setback
- Updated version 2 - Packaging companies Silgan and American Industrial to acquire Trivium Packaging for $3.4 billion
- Goldman Sachs warns of the risk of increased market volatility
- BofA Securities Adjusts Eastman Chemical Price Target to $85 From $87, Maintains Buy Rating
- BofA Securities Adjusts Albemarle Price Target to $131 From $155, Maintains Buy Rating
- Blue Moon Metals Raises CA$35 Million Via Non-Brokered Private Placement with The Elmet Group
- Stoneridge publishes update to financial calendar
- Four Nines Gold Intersects 80.1 Meters Grading 1.08 g/t Gold at Hayden Hill
- UPM Names Aki Temmes CFO Effective Jan. 1, 2027
- LADDER CAPITAL CORP <LADR.N>: B. RILEY CUTS TARGET PRICE TO $12 FROM $13
- Eastnine Announces Annual General Meeting
- CINEMARK HOLDINGS INC <CNK.N>: B. RILEY RAISES TARGET PRICE TO $42 FROM $37
- BlackRock's stake in Kesko rises above 5% to 5.12%
- Strive Buys 4,045 Bitcoin, Lifting Holdings to 36,818
- FDA Accepts UroGen's UGN-103 Application for Bladder Cancer Treatment
- AMC ENTERTAINMENT HOLDINGS, INC. : B. RILEY RAISES TARGET PRICE TO $3.25 FROM $2.50
- Ripple's Big Event in 7 Days: All Eyes on AI and XRP Ledger Security
- -- Earnings Flash (DX) Dynex Capital, Inc. Posts Q3 Adjusted EPS $0.38 per Share
- Silgan to Form New Business With Planned Trivium Packaging Acquisition
- Xanadu Receives Provisional Approval for $10 Million Contract Extension From DARPA
- Tech Stock Rebound Nudges US Equity Futures Mostly Higher Pre-Bell
- -- Earnings Flash (DX) Dynex Capital, Inc. Reports Q3 Net Interest Income $101.6M
- Evercore Names John Vaske Senior Managing Director in Chemicals Investment Banking
- Fortress Real Estate CEO Steven Brown pledges additional shares worth R 29.71 million as loan security
- Traction Uranium Completes Initial Drilling at Aurora Project
- BASF, HSCC Explore 50:50 European Polyamide 6 Joint Venture
- DMS Propertindo Announces Extraordinary Shareholders Meeting
- BUZZ - Traders say Abivax's stock price fell due to the release of data from a competitor's drug.
- United Therapeutics Gets FDA Clearance to Start Phase 2 Trial of Treprostinil Soft Mist Inhaler
- BUZZ - Brokerages say that data center financing will be one of the key themes in upcoming asset management company financial reports.
- Barito Renewables Says No Undisclosed Material Information Behind Trading Volatility
- Western Gold Exploration Names Tom Fraser CEO
- INPLAY OIL CORP <IPO.TO>: ATB CORMARK CAPITAL MARKETS RAISES TARGET PRICE TO C$25 FROM C$23
- Cullinan Therapeutics, Taiho Oncology Report 30.2% Intracranial Response Rate in Phase 2 Cancer Trial
- EyePoint's Duravyu Misses Primary Endpoint in Second Phase 3 Wet AMD Trial; Shares Fall Pre-Bell
- Trinity Silver reports silver grades up to 82 g/t at Nueva Chañarcillo tailings
- B. Riley Lowers Price Target on Onto Innovation to $340 From $390, Keeps Buy Rating
- Centrus Energy Acquires Westerman for $116 Million to Expand Manufacturing
- NASDAQ TRADE HALT <SLN.O> HALT NEWS PENDING AT 07:55 AM
- NASDAQ TRADE HALT CONTINUES <TJGC.O> REASON NOT AVAILABLE AT 07:55 AM
- BofA Securities Adjusts Eli Lilly Price Target to $1,397 From $1,341, Maintains Buy Rating
- --NRG Energy Keeps Quarterly Dividend at $0.475 a Share, Payable Nov. 16 to Shareholders of Record as of Nov. 2
- Deutsche Bank hosts emerging markets conference in Bangkok
- Palantir Technologies Forms New Partnership With Knox Systems
- Insmed Launches Brinsupri Tablet in Japan for Non-Cystic Fibrosis Bronchiectasis
- Localiza announces R$ 1 billion debenture offering
- Localiza Board Approves R$ 1 Billion Debenture Issue
- HDFC Bank seeks shareholder approval for Lily Vadera’s three-year reappointment as independent director
- BUZZ-Disc Medicine shares soar as rare disease drug performs excellently in key trial
- B. Riley Cuts Price Target on Ladder Capital to $12 From $13, Keeps Buy Rating
- Blue Sky Uranium Starts Field Programs to Test New Discovery Potential at Amarillo Grande in Argentina
- Altius Minerals’ Equity Portfolio Value Rises to $97.6 Million in Third Quarter
- I-80 GOLD CORP <IAU.TO>: ATB CORMARK CAPITAL MARKETS RAISES TARGET PRICE TO C$4 FROM C$3.50
- --HC Wainwright Initiates Hadron Energy at Buy With $4.50 Price Target
- BMO Capital Adjusts Marathon Petroleum Price Target to $535 From $455
- B. Riley Cuts Price Target on Ichor Holdings to $85 From $105, Keeps Buy Rating
- OCEANAGOLD CORP <OGC.TO>: RAYMOND JAMES CUTS TARGET PRICE TO C$52 FROM C$53
- KINROSS GOLD CORPORATION <KGC.N>: RAYMOND JAMES CUTS TARGET PRICE TO $32 FROM $33
- DOGE Nears Key Breakout Zone With $0.10 Target in Focus
- Top Premarket Decliners
- Automob Q3 Gross Revenue Rises 9% to R$ 4.01 Billion
- IAMGOLD CORP <IAG.N>: RAYMOND JAMES CUTS TARGET PRICE TO $20.5 FROM $21
- Golar LNG announces Q3 results presentation
- Boozt Announces Annual General Meeting
- EyePoint will lay off half of its staff after the failure of the second late-stage clinical trial of its experimental drug.
- B2GOLD CORP. <BTG.N>: RAYMOND JAMES CUTS TARGET PRICE TO $7.25 FROM $7.5
- Dogecoin whales accumulate 600 million DOGE as price defends $0.08
- AXCELIS TECHNOLOGIES, INC. : B. RILEY CUTS TARGET PRICE TO $165 FROM $198
- NASDAQ TRADE HALT CONTINUES <TJGC.O> REASON NOT AVAILABLE AT 07:45 AM
- AGNICO EAGLE MINES LIMITED : RAYMOND JAMES CUTS TARGET PRICE TO $200 FROM $225
- Advantage Solutions Tightens Bylaw Requirements for Stockholder Director Nominations
- ONTO INNOVATION INC. <ONTO.N>: B. RILEY CUTS TARGET PRICE TO $340 FROM $390
- TriGemX Bio to Go Public Through TCGX SPAC Merger
- ESTÉE LAUDER <EL.N>: JEFFERIES RAISES TARGET PRICE TO $120 FROM $100
- Allied Properties REIT Appoints Donald Clow to Board
- Eneva Q3 Net Thermal Power Generation Falls 38% to 2,105 GWh
- SKINHEALTH SYSTEMS INC <SKIN.O>: JEFFERIES RAISES TARGET PRICE TO $11 FROM $0.85
- FORMFACTOR INC : B. RILEY CUTS TARGET PRICE TO $150 FROM $165
- COTY INC <COTY.N>: JEFFERIES RAISES TARGET PRICE TO $2.95 FROM $2.4
- GEO Redeems Entire Outstanding Principal of $650 Million Senior Secured Notes due 2029
- Thai Beverage Unit InterBev Establishes VinaBeCo Subsidiary in Vietnam
- E.L.F. BEAUTY, INC. <ELF.N>: JEFFERIES RAISES TARGET PRICE TO $132 FROM $100
- LAM RESEARCH <LRCX.O>: B. RILEY CUTS TARGET PRICE TO $338 FROM $390
- Barclays Downgrades OGE Energy to Equalweight, Price Target is $48
- Immunic Expects Funding to Last Into Late 2027
- BMO Capital Adjusts Baker Hughes Price Target to $64 From $68
- CANADIAN NATIONAL RAILWAY CO <CNR.TO>: RAYMOND JAMES CUTS TO MARKET PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO C$195 FROM C$200
- DRAFTKINGS INC. <DKNG.O>: MORGAN STANLEY CUTS TARGET PRICE TO $31 FROM $36
- RED ROCK RESORTS, INC. <RRR.O>: MORGAN STANLEY CUTS TARGET PRICE TO $59 FROM $61
- PENN ENTERTAINMENT, INC. : MORGAN STANLEY CUTS TARGET PRICE TO $18 FROM $20
- CITIZENS FINANCIAL <CFG.N>: RAYMOND JAMES CUTS TARGET PRICE TO $76 FROM $77
- LAS VEGAS SANDS CORP. <LVS.N>: MORGAN STANLEY CUTS TARGET PRICE TO $55 FROM $61
- MGM RESORTS INTERNATIONAL <MGM.N>: MORGAN STANLEY CUTS TARGET PRICE TO $29 FROM $43
- M&T BANK CORPORATION <MTB.N>: RAYMOND JAMES CUTS TARGET PRICE TO $245 FROM $250